Increased NO-synthase activity and beneficial effect of PDE-5 inhibition by sildenafil in pulmonary hypertension caused by pulmonary embolism

被引：0
|
作者：
Mizera, Roman [1 ,2 ]
Hodyc, Daniel [1 ]
Herget, Jan [1 ]
机构：
[1] 2nd Med Sch Prague, Prague 5, Czech Republic
[2] KNL, Traumatol Orthopad Ctr, Liberec 1, Czech Republic
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
LB646
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MULTIFUNCTIONALILTY OF SILDENAFIL, AN PDE-5 INHIBITOR - PULMONARY VASODILATATION AND BEYOND
    Saji, Tsutomu
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 45 - 45
  • [2] Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition
    Groeneveldt, Joanne A.
    Gans, Steven J. M.
    Bogaard, Harm J.
    Vonk-Noordegraaf, Anton
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 869 - 870
  • [3] Beneficial effect of moxonidine in hypertension induced by NO-synthase inhibition
    Gairard, A
    Beck, JF
    Van Overloop, B
    Pernot, F
    LaRoche, B
    Christen, MO
    JOURNAL OF HYPERTENSION, 1998, 16 : S98 - S98
  • [4] Transition From Pde-5 Inhibitors To Riociguat In Pulmonary Hypertension
    Weir, N.
    Brown, A. W.
    DelaSantina, J.
    King, C.
    Lewis, D.
    Franco-Palacios, D.
    Nathan, S. D.
    Shlobin, O. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension
    Deibert, P.
    Bremer, H.
    Roessle, M.
    Kurz-Schmieg, A-K.
    Kreisel, W.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (01) : 220 - 221
  • [6] Phosphodiesterase 5 (PDE5) enzyme activity is increased in lambs with increased pulmonary blood flow and pulmonary hypertension
    Sanchez, LS
    Fineman, JR
    Barry, AJ
    Black, SM
    PEDIATRIC RESEARCH, 1999, 45 (04) : 318A - 318A
  • [7] Phosphodiesterase 5 (PDE5) Enzyme Activity Is Increased in Lambs with Increased Pulmonary Blood Flow and Pulmonary Hypertension
    Lucienne S Sanchez
    Jeffrey R Fineman
    Andrew J Barry
    Stephen M Black
    Pediatric Research, 1999, 45 (7) : 318 - 318
  • [8] Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension
    Guilluy, C
    Sauzeau, V
    Rolli-Derkinderen, M
    Guérin, P
    Sagan, C
    Pacaud, P
    Loirand, G
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (07) : 1010 - 1018
  • [9] The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
    Dias, CA
    Souza-Costa, DC
    Zerbini, T
    da Rocha, JBT
    Gerlach, RF
    Tanus-Santos, JE
    ANESTHESIA AND ANALGESIA, 2005, 101 (01): : 115 - 120
  • [10] Inadequate Diagnostic Testing for Patients Started on PDE-5 Inhibitors for Pulmonary Hypertension
    Matusov, Y.
    Wei, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345